vanda pharmaceuticals inc
Richard W. Dugan
Director and Chairman of Audit Committee, Vanda Pharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 13 board members in 2 different organizations across 2 different industries.|
See Board Relationships
Mr. Richard W. Dugan served as a Partner of Ernst & Young LLP, from 1976 to September 2002. Mr. Dugan served in a variety of managing and senior partner positions at Ernst & Young LLP, including Mid-Atlantic Area Senior Partner from 2001 to 2002, Mid-Atlantic Area Managing Partner from 1989 to 2001 and Pittsburgh Office Managing Partner from 1981 to 1989. He retired from Ernst & Young LLP in September 2002. Mr. Dugan has been a Director at Vanda Pharmaceuticals, Inc. ...
2200 Pennsylvania Avenue NWPhone: 202-734-3400
Washington, District Of Columbia 20037
Board Members Memberships*
Former Director, Chairman of Audit Committee and Member of Compensation Committee
Former Lead Independent Director, Chairman of Audit Committee and Member of Nominating & Corporate Governance Committee
Director and Chairman of Audit Committee
Pennsylvania State University
Annual Compensation*There is no Annual Compensation data available.
|John C. Lechleiter Ph.D.||Chairman, Chief Executive Officer and President|
Eli Lilly and Company
|Pascal Soriot||Chief Executive Officer, Executive Director and Member of Disclosure Committee|
|Christopher A. Viehbacher||Chief Executive Officer, Director and Member of Strategy Committee|
|Masayo Tada||Chief Executive Officer, President, Representative Director and Chairman of Risk Management Committee|
Sumitomo Dainippon Pharma Co., Ltd.
|Glenn A. Oclassen Sr.||Chairman of the Board, Chief Executive Officer and President|
Transcept Pharmaceuticals, Inc.
|$560.0K||Compensation as of Fiscal Year 2013.|